KMT2A and leukemia: To isolate leukemia cells resistant to cytolysis by CTLs, MLL/AF9 leukemia cells were transduced with ovalbumin (OVA) as a model tumor cell antigen, and then co-cultured with OVA-specific T cells derived from OT-1 transgenic mice.